Advertisement
Advertisement
U.S. markets close in 3 hours 19 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Rigel Pharmaceuticals, Inc. (RIGL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
1.0850-0.0050 (-0.46%)
As of 12:41PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Performance Outlook
Previous Close1.0900
Open1.0900
Bid1.0800 x 1400
Ask1.0900 x 1800
Day's Range1.0500 - 1.1000
52 Week Range0.6700 - 2.0400
Volume173,596
Avg. Volume1,143,296
Market Cap189.185M
Beta (5Y Monthly)0.69
PE Ratio (TTM)N/A
EPS (TTM)-0.2100
Earnings DateNov 01, 2023 - Nov 06, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.17
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for RIGL

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Rigel Pharmaceuticals, Inc.
    Analyst Report: Eli Lilly and CompanyEli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
    Rating
    Fair Value
    Economic Moat
    4 days agoMorningstar
View more
Advertisement
Advertisement